ENTRY       D02168                      Drug
NAME        Topotecan hydrochloride (USAN);
            Nogitecan hydrochloride (JAN);
            Hycamtin (TN);
            Potactasol (TN)
PRODUCT     HYCAMTIN (Novartis Pharmaceuticals Corporation)
            HYCAMTIN (Novartis Pharmaceuticals Corporation)
            TOPOTECAN (Hospira)
            TOPOTECAN (Teva Parenteral Medicines)
  GENERIC   TOPOTECAN (Accord Healthcare)
            TOPOTECAN HYDROCHLORIDE (Accord Healthcare)
            TOPOTECAN HYDROCHLORIDE (Actavis Pharma)
            TOPOTECAN HYDROCHLORIDE (Bedford Laboratories)
            TOPOTECAN HYDROCHLORIDE (Fresenius Kabi USA)
            TOPOTECAN HYDROCHLORIDE (Fresenius Kabi USA)
FORMULA     C23H23N3O5. HCl
EXACT_MASS  457.1404
MOL_WEIGHT  457.9068
CLASS       Antineoplastic
             DG01529  Topoisomerase inhibitor
              DG01526  Topoisomerase I inhibitor
            Transporter substrate
             DG01665  ABCB1 substrate
             DG02920  ABCC4 substrate
             DG01913  ABCG2 substrate
REMARK      Therapeutic category: 4240
            ATC code: L01CE01
            Chemical structure group: DG00725
            Product (DG00725): D02168<JP/US>
EFFICACY    Antineoplastic, Topoisomerase I inhibitor
  DISEASE   Small cell lung cancer [DS:H00013]
            Ovarian cancer [DS:H00027]
            Cervical cancer [DS:H00030]
COMMENT     Camptothecin [CPD:C01897] derivative
TARGET      TOP1 [HSA:7150] [KO:K03163]
METABOLISM  Transporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429], ABCC4 [HSA:10257]
INTERACTION  
STR_MAP     map07042  Antineoplastics - agents from natural products
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
                L01CE Topoisomerase 1 (TOP1) inhibitors
                 L01CE01 Topotecan
                  D02168  Topotecan hydrochloride (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Molecular Target Inhibitors
               Topotecan
                D02168  Topotecan hydrochloride (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               424  Plant extract preparations
                4240  Plant extract preparations
                 D02168  Topotecan hydrochloride (USAN); Nogitecan hydrochloride (JAN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01529  Topoisomerase inhibitor
               DG01526  Topoisomerase I inhibitor
                DG00725  Topotecan
                 D02168  Topotecan hydrochloride
             Transporter substrate
              DG01665  ABCB1 substrate
               DG00725  Topotecan
                D02168  Topotecan hydrochloride
              DG02920  ABCC4 substrate
               DG00725  Topotecan
                D02168  Topotecan hydrochloride
              DG01913  ABCG2 substrate
               DG00725  Topotecan
                D02168  Topotecan hydrochloride
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Isomerases (EC5)
               DNA topoisomerase
                TOP1
                 D02168  Topotecan hydrochloride (USAN) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D02168
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D02168
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug transporters
              D02168
            Drug groups [BR:br08330]
             Antineoplastic
              DG01529  Topoisomerase inhibitor
               DG01526  Topoisomerase I inhibitor
                DG00725  Topotecan
             Transporter substrate
              DG01665  ABCB1 substrate
               DG00725  Topotecan
              DG02920  ABCC4 substrate
               DG00725  Topotecan
              DG01913  ABCG2 substrate
               DG00725  Topotecan
DBLINKS     CAS: 119413-54-6
            PubChem: 7849229
            LigandBox: D02168
            NIKKAJI: J2.173.467E
ATOM        32
            1   C8y C    32.0215  -19.7287
            2   C8y C    29.7683  -20.8552
            3   N4y N    30.6133  -19.7285
            4   C1x C    29.7683  -18.6020
            5   C8y C    28.4540  -20.4326
            6   C8y C    28.4540  -19.0244
            7   C8x C    27.2336  -18.3673
            8   N5x N    27.2336  -21.1367
            9   C8y C    26.0131  -20.4796
            10  C8y C    26.0131  -19.0714
            11  C8y C    24.8396  -18.3673
            12  C8y C    23.6191  -19.0714
            13  C8x C    23.6191  -20.4796
            14  C8x C    24.8396  -21.1838
            15  C1b C    24.8396  -17.0060
            16  N1c N    23.6191  -16.3019
            17  C1a C    23.6191  -14.8937
            18  C1a C    22.4456  -17.0060
            19  O1a O    22.3987  -18.4143
            20  O5x O    32.7141  -18.5298
            21  C8y C    32.7340  -20.9631
            22  C1x C    34.1280  -20.9630
            23  C8y C    32.0340  -22.1755
            24  C8x C    30.6115  -22.1758
            25  O7x O    34.8251  -22.1700
            26  C7x C    34.1346  -23.3658
            27  C1z C    32.7215  -23.3659
            28  O6a O    34.8251  -24.5616
            29  C1b C    31.3147  -23.3660
            30  C1a C    30.6287  -24.5679
            31  O1a O    32.7215  -24.7659
            32  X   Cl   36.6837  -19.7288
BOND        35
            1     2   3 1
            2     3   4 1
            3     4   6 1
            4     5   2 1
            5     5   6 2
            6     6   7 1
            7     7  10 2
            8     9   8 2
            9     8   5 1
            10    9  10 1
            11   10  11 1
            12   11  12 2
            13   12  13 1
            14   13  14 2
            15   14   9 1
            16   11  15 1
            17   15  16 1
            18   16  17 1
            19   16  18 1
            20    3   1 1
            21   12  19 1
            22    1  20 2
            23    1  21 1
            24   21  22 1
            25   21  23 2
            26   23  24 1
            27   24   2 2
            28   22  25 1
            29   25  26 1
            30   26  27 1
            31   27  23 1
            32   26  28 2
            33   27  29 1 #Down
            34   29  30 1
            35   27  31 1 #Up
///
